Image: US Military Health
Science ministry assigns €41 million budget in bid to combat rise in resistant germs
Germany’s science ministry has announced that it will back a non-profit initiative on antibiotic-resistant bacteria with €41 million for four years, following an initial investment in 2019.
The funds are going to the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (Carb-X), which has been funding projects on therapeutics, vaccines and diagnostics against antibiotic-resistant bacteria worldwide since 2016. Carb-X is based at Boston University in the United States, and is researching methods to combat antibiotic resistance, where germs become immune to medicines designed to treat them.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.